Directorate Change

CT Private Equity Trust PLC
19 December 2023
 

To:                          RNS

From:                    CT Private Equity Trust PLC ("the Company")

Date:                     19 December 2023

 

 

Directorate Change

 

As part of the Company's plan to ensure an orderly succession as Directors retire, an independent search company was commissioned to find a new director for the Board.  Following a thorough selection process, conducted by the search company, CT Private Equity Trust PLC is pleased to announce that Craig Armour has been appointed to the Board with effect from today, 19 December 2023.

 

Until 2021 Craig was an investment partner at Edinburgh Partners where his roles included head of European portfolios and the manager of The European Investment Trust PLC. Previously, he was a senior investment director at Lloyds Development Capital, a partner at Penta Capital, and a corporate financier at Noble Grossart.

 

It is anticipated that Craig, a member of the Institute of Chartered Accountants of Scotland, will be appointed the Chair of the Audit Committee following the retirement of Elizabeth Kennedy at the forthcoming 2024 Annual General Meeting of the Company.

 

We look forward to working with Craig and to the valuable insights that he will bring to the Board's deliberations.

 

Legal Entity Identifier: 2138009FW98WZFCGRN66

 

For more information, please contact:

 

Hamish Mair (Investment Manager)

0131 573 8314

Scott McEllen (Company Secretary)

0131 573 8372

hamish.mair@columbiathreadneedle.com  / scott.mcellen@columbiathreadneedle.com



 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings